"Designing Growth Strategies is in our DNA"

Dermatology Devices Market Size, Share & Industry Analysis, By Device Type (Diagnostic Devices {Dermatoscopes, Microscopes, and Others} and Treatment Devices {Light Therapy Devices, Lasers, Microdermabrasion Devices, and Others}), By End-user (Hospitals, Dermatology Clinics, and Others), and Regional Forecast, 2026-2034

Region : Global | Report ID: FBI115599 | Status : Ongoing

 

KEY MARKET INSIGHTS

The global dermatology devices market is experiencing significant growth, primarily driven by the increasing demand for dermatological treatments due to the high incidence of dermatological disorders, including acne, eczema, and skin cancer. Furthermore, the introduction of AI-enabled diagnostic imaging, handheld digital dermatoscopes, and robotic-assisted treatment systems is further supporting the growth of the dermatology devices market.

  • For instance, according to data published by the American Academy of Dermatology Association (AAD) in February 2025, acne affects nearly 50.0 million U.S. individuals each year.

Dermatology Devices Market Driver

Rising Number of Skin Disorders to Fuel Market Growth

Over the past few years, there has been a significant increase in skin conditions, including melanoma, eczema, psoriasis, and others. This is driving the demand for diagnostic devices such as dermatoscopes and microscopes, and others. Furthermore, it is also driving the demand for treatment devices, such as dermatology lasers, among other medical devices. Such a scenario is encouraging key players to launch new products, which is expected to drive the global market growth. 

  • For instance, according to data published by the National Center for Biotechnology Information (NCBI) in 2023, between 2009 and 2019, the U.S. recorded an estimated increase of more than 40.0% in new melanoma cases.

Download Free sample to learn more about this report.

According to data published by the American Academy of Dermatology Association (AAD) in February 2025, acne affects nearly 50.0 million U.S. individuals. Atopic dermatitis affects nearly 1 in 10, hair loss affects nearly 80 million, and psoriasis affects nearly 7.5 million individuals.

Dermatology Devices Market Restraint

High Cost of Advanced Dermatology Devices May Hinder Market Growth

Despite a high demand for diagnostic and treatment devices, the high acquisition and maintenance costs of technologies such as laser systems, phototherapy units, and digital dermatoscopes are limiting adoption, especially among small and mid-sized dermatology clinics. Moreover, the higher treatment costs, such as laser resurfacing, are also decreasing product adoption. This is anticipated to hinder market growth in the years to come.

  • For instance, in May 2024, Athena Skin & Laser stated that the average total cost of laser skin resurfacing ranges from USD 2,000 to USD 6,000, depending on the extent of the treatment.

Dermatology Devices Market Opportunity

Growing Adoption of AI and Digital Imaging in Skin Diagnostics to Offer Lucrative Opportunities

Recently, the integration of artificial intelligence (AI) and high-resolution imaging has allowed for the early and accurate detection of skin cancers and other dermatological conditions. This enhances diagnostic efficiency and patient outcomes, prompting key players to develop and launch innovative devices for dermatological diagnosis, thereby offering lucrative market growth opportunities.

  • For instance, in January 2024, the U.S. FDA granted clearance to the DermaSensor, the first AI-powered device approved for use by primary care physicians in detecting the three most common types of skin cancer, including melanoma, basal cell carcinoma, and squamous cell carcinoma.

Segmentation

By Device Type

By End-user

By Geography

  • Diagnostic Devices

o    Dermatoscopes

o    Microscopes

o    Others

  • Treatment Devices

o    Light Therapy Devices

o    Lasers

o    Microdermabrasion Devices

o    Others

  • Hospitals
  • Dermatology Clinics
  • Others

·      North America (U.S. and Canada)

·      Europe (U.K., Germany, France, Spain, Italy, Scandinavia, and the Rest of Europe)

·      Asia Pacific (Japan, China, India, Australia, Southeast Asia, and the Rest of Asia Pacific)

·      Latin America (Brazil, Mexico, and the Rest of Latin America)

·      Middle East & Africa (South Africa, GCC, and Rest of the Middle East & Africa)

Key Insights

The report covers the following key insights:

  • Prevalence/Incidence of Key Diseases, By Key Countries/ Region, 2024
  • Number of Key Procedures, By Key Countries/ Region, 2024
  • Advancements in Dermatology Devices
  • Key Industry Developments - (Mergers, Acquisitions & Partnerships, and Others)

Analysis by Device Type

The market, based on device type, has been studied across diagnostic devices {dermatoscopes, microscopes, and others}, and treatment devices {light therapy devices, lasers, microdermabrasion devices, and others}.

The treatment devices segment held the largest market share in 2024. Treatment devices, such as light therapy systems, lasers, and microdermabrasion units, are used across a wide range of therapeutic and cosmetic procedures, including scar removal, hair removal, skin rejuvenation, wrinkle reduction, vascular lesion treatment, and pigmentation correction. This is expected to drive the demand for these devices, propelling the segment’s growth.

Analysis by End-user

By end-user, the market is categorized into hospitals, dermatology clinics, and others.

The hospitals segment held the largest market share in 2024.  The majority of dermatological procedures are performed in hospitals due to the availability of experts and advanced equipment. This is driving patient visits to these settings, which in turn fuels the utilization of dermatological devices. Moreover, a significant number of hospitals globally are contributing to the adoption of such devices, fueling the segment’s growth.

  • For instance

Regional Analysis

Request for Customization   to gain extensive market insights.

The market, on the basis of region, has been analyzed across Europe, North America, Latin America, Asia Pacific, and the Middle East & Africa. 

North America held the largest share of the global dermatology devices market in 2024. There is a rise in the number of aesthetic and minimally invasive skin procedures, driven by the consumer focus on appearance and preventive skincare in the U.S. and Canada. This is attracting key players to ensure the consistent device availability, which is expected to drive the regional market growth.

  • For instance, according to data published by the American Board of Facial Cosmetic Surgery, approximately 500,000 cosmetic laser treatments were performed in 2021, representing a 59.0% increase from 2020.

Asia Pacific is expected to grow at the highest CAGR during the analysis period. The growth is attributed to the increasing geriatric population in countries such as China and India. Aging individuals are more susceptible to skin aging, pigmentation, and certain types of cancer, which is expected to boost both diagnostic and treatment device utilization in the years to come.

Key Players Covered

The global dermatology devices market is led by key players such as Cynosure UK Ltd, Solta Medical, Cutera, Inc., and others. These companies are increasing device supply to dermatology clinics and hospitals to gain a significant market share.

The report includes the profiles of the following key players:

  • Alma Lasers (Israel)
  • Cynosure UK Ltd (U.K.)
  • Solta Medical (U.S.)
  • Cutera, Inc. (U.S.)
  • Syneron Medical Ltd. (Israel)
  • Canfield Scientific, Inc. (U.S.)
  • AGS-Medical. (U.S.)
  • Aesthetic Group (France)
  • Gima S.p.A. (Italy)
  • co.kr (South Korea)

Key Industry Developments

  • October 2025: DermaSensor raised USD 16.0 million in Series B funding to expand the commercial reach of its FDA-cleared, AI-powered handheld skin cancer detection device, targeting primary care physicians.
  • May 2025: AI Medical Technology’s (AIM) Dermalyser, an AI-driven diagnostic tool for melanoma detection, received CE Mark certification, enabling its commercial use across Europe. The smartphone-integrated tool demonstrated superior accuracy.


  • Ongoing
  • 2025
  • 2021-2024
Download Free Sample

    man icon
    Mail icon

Get 20% Free Customization

Expand Regional and Country Coverage, Segments Analysis, Company Profiles, Competitive Benchmarking, and End-user Insights.

Growth Advisory Services
    How can we help you uncover new opportunities and scale faster?
Healthcare Clients
3M
Toshiba
Fresenius
Johnson
Siemens
Abbot
Allergan
American Medical Association
Becton, Dickinson and Company
Bristol-Myers Squibb Company
Henry Schein
Mckesson
Mindray
National Institutes of Health (NIH)
Nihon Kohden
Olympus
Quest Diagnostics
Sanofi
Smith & Nephew
Straumann